DPP4 and Hypertension: This report details a complex case of a 94-year-old woman with new-onset BP following dipeptidyl peptidase-4 (DPP-4) inhibitor (linagliptin) initiation, complicated by diabetes mellitus, chronic kidney disease, hypertension, and dementia.